In Florida, California, and Illinois, researchers from several universities have found that two molecules in the immune system are crucial to drug resistance in breast cancers. Most breast cancer tumors are compelled by estrogen and drug treatments often include estrogen suppression, but unfortunately about half of patients don’t respond to those treatments. However, now that researchers know that two molecules, called interleukin 1 beta and tumor necrosis factor alpha, are responsible for the drug resistance in patients, it offers researchers key insights. Researchers hope to use the information and genomic, cellular and biochemical approaches to develop new treatments to block the resistance process for breast cancer patients.
Latest article
Fungi flex: JadeYoga’s mushroom yoga mat combines ‘innovation and integrity’
In Pennsylvania, sustainable yoga products maker JadeYoga has introduced a new yoga mat using only natural rubber and repurposed mushroom material.
Dubbed Jade Mushroom Mat™,...
Sumang seeks functional biomaterials on volcanic island
In South Korea, green tea and agricultural cooperative Sumang has announced plans to expand its R&D efforts on functional biomaterials sourced from Jeju, a...
Tree to tech: Empa creates wooden computer mouse
In Switzerland, the Swiss Federal Laboratories for Materials Science and Technology (Empa) has created a computer mouse that works like any other, expect it...